As the US addresses its budget dilemma, the easiest items to cut are those with the longest-term payoff. Research stands out among this group. Biomedical research has already been markedly reduced, and further reductions appear to be in store. As a frequent witness in Congressional hearings on such matters, here I discuss the challenge of assessing the value of investments in biomedical research.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348965 | PMC |
http://dx.doi.org/10.1172/JCI79617 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!